000			02026 a2200613 4500
005			20250516080434.0
264		0	_c20121119
008			201211s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2012.47 _2doi
040			_aNLM _beng _cNLM
100	1		_aCurik, N
245	0	0	_a5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity. _h[electronic resource]
260			_bLeukemia _cAug 2012
300			_a1804-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntimetabolites, Antineoplastic _xpharmacology
650	0	4	_aAzacitidine _xpharmacology
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aChromatin _xgenetics
650	0	4	_aColony-Stimulating Factors _xpharmacology
650	0	4	_aDNA Methylation _xdrug effects
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Leukemic _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyelodysplastic Syndromes _xdrug therapy
650	0	4	_aNeoplastic Stem Cells _xcytology
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aRegulatory Sequences, Nucleic Acid _xdrug effects
650	0	4	_aTrans-Activators _xgenetics
650	0	4	_aTranscriptional Activation _xdrug effects
700	1		_aBurda, P
700	1		_aVargova, K
700	1		_aPospisil, V
700	1		_aBelickova, M
700	1		_aVlckova, P
700	1		_aSavvulidi, F
700	1		_aNecas, E
700	1		_aHajkova, H
700	1		_aHaskovec, C
700	1		_aCermak, J
700	1		_aKrivjanska, M
700	1		_aTrneny, M
700	1		_aLaslo, P
700	1		_aJonasova, A
700	1		_aStopka, T
773	0		_tLeukemia _gvol. 26 _gno. 8 _gp. 1804-11
856	4	0	_uhttps://doi.org/10.1038/leu.2012.47 _zAvailable from publisher's website
999			_c21553846 _d21553846